Development of androgen- and estrogen-responsive bioassays members of a panel of human cell line-based highly selective steroid-responsive bioassays

Toxicological Sciences

Volumn 83, Issue 1, 2005, Pages 136-148

  Sonneveld, Edwin ^a   Jansen, Hendrina J ^a   Riteco, Jacoba A C ^a   Brouwer, Abraham ^a,b   van der Burg, Bart ^a  

^a BIODETECTION SYSTEMS B V   (Netherlands)

^b INSTITUTE FOR ENVIRONMENTAL STUDIES   (Netherlands)

Author keywords

Androgen; Bioassay; CALUX; Estrogen; Luciferase; Receptor

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; ANDROGEN RECEPTOR; ANDROSTANOLONE; CHLORPHENOTANE; CYPROTERONE ACETATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FLUTAMIDE; GESTAGEN; GLUCOCORTICOID; LUCIFERASE; METHOXYCHLOR; VINCLOZOLIN;

ARTICLE; BIOASSAY; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OSTEOSARCOMA; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TATA BOX; WESTERN BLOTTING;

ANDROGENS; BIOLOGICAL ASSAY; CELL LINE, TUMOR; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENES, REPORTER; GLUCOCORTICOIDS; HUMANS; LIGANDS; LUCIFERASES; MAMMARY TUMOR VIRUS, MOUSE; PROGESTINS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; STEROIDS; TRANSFECTION;

EID: 12344265705     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi005     Document Type: Article

References (52)

1. Andersen, H. R., Vinggaard, A. M., Rasmussen, T. H., Gjermandsen, I. M., and Bonefeld-Jorgensen, E. C. (2002). Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol. Appl. Pharmacol. 179, 1-12.
2. Aurrekoetxea-Hernandez, K., and Buetti, E. (2004). Transforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteins. J. Virol. 78, 2201-2211.
3. Avances, C., Georget, V., Terouanne, B., Orio, F., Cussenot, O., Mottet, N., Costa, P., and Sultan, C. (2001). Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. Mol. Cell. Endocrinol. 184, 13-24.
4. Bentel, J. M., Birrell, S. N., Pickering, M. A., Holds, D. J., Horsfall, D. J., and Tilley, W. D. (1999). Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol. Cell. Endocrinol. 154, 11-20.
5. Blankvoort, B. M., de Groene, E. M., van Meeteren-Kreikamp, A. P., Witkamp, R. F., Rodenburg, R. J., and Aarts, J. M. (2001). Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. Anal. Biochem. 298, 93-102.
6. Brinkmann, A. O., Faber, P. W., van Rooij, H. C., Kuiper, J. M., Ris, C., Klaassen, P., van der Korput, J. A. G. M., Voorhorst, M. M., van Laar, J. H., Mulder, E., et al. (1989). The human androgen receptor: Domain structure, genomic organization and regulation of expression. J. Steroid Biochem. 34, 307-310.
7. Claessens, F., Verrijdt, G., Schoenmakers, E., Haelens, A., Peeters, B., Verhoeven, G., and Rombauts, W. (2001). Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J. Steroid Biochem. Mol. Biol. 76, 23-30.
8. de Gooyer, M. E., Deckers, G. H., Schoonen, W. G. E. J., Verheul, H. A., Kloosterboer, H. J. (2003). Receptor profiling and endocrine interactions of tibolone. Steroids 68, 21-30.
9. Di Croce, L., Koop, R., Venditti, P., Westphal, H. M., Nightingale, K. P., Corona, D. F., Becker, P. B., and Beato, M. (1999). Two-step synergism between the progesterone receptor and the DNA-binding domain of nuclear factor 1 on MMTV minichromosomes. Mol. Cell 4, 45-54.
10. Dubbink, H. J., Hersmus, R., Verma, C. S., van der Korput, H. A., Berrevoets, C. A., van Tol, J., Ziel-Van Der Made, A. C., Brinkmann, A. O., Pike, A. C., and Trapman, J. (2004). Distinct recognition modes of FXXLF and LXXLL motifs by the androgen Receptor. Mol. Endocrinol. 18, 2132-2150.
11. Evans, N. A. (2004). Current concepts in anabolic-androgenic steroids. Am. J. Sports Med. 32, 534-542.
12. Folkers, G. E., and van der Saag P. T. (1995). Adenovirus E1A functions as a cofactor for retinoic acid receptor beta (RAR beta) through direct interaction with RAR beta. Mol. Cell. Biol. 15, 5868-5878.
13. Gibson, M. K., Nemmers, L. A., Beckman, W. C., Davis, V. L., Curtis, S. W., and Korach, K. S. (1991). The mechanism of ICI-164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129, 2000-2010.
14. Gimeno, S., Gerritsen, A., Bowmer, T., and Komen, H. (1996). Feminization of male carp. Nature 384, 221-222.
15. Glass, C. K. (1994). Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15, 391-407.
16. Green, S., Walter, P., Greene, G., Krust, A., Goffin, C., Jensen, E., Scrace, G., Waterfield, M., and Chambon, P. (1986). Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 24, 77-83.
17. Hartig, P. C., Bobseine, K. L., Britt, B. H., Cardon, M. C., Lambright, C. R., Wilson, V. S., and Gray, L. E., Jr. (2002). Development of two androgen receptor assays using adenoviral transduction of MMTV-Luc reporter and/or hAR for endocrine screening. Toxicol. Sci. 66, 82-90.
18. He, B., Lee, L. W., Minges, J. T., and Wilson, E. M. (2002). Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J. Biol. Chem. 277, 25631-25639.
19. Interagency Coordinating Committee on the Validation of Alternative Methods (ICVAMM) (2003). ICCVAM evaluation of in vitro test methods for detection of potential endocrine disruptors: Estrogen receptor and androgen receptor binding and transcriptional activation assays. NIH publication no. 03-4503.
20. Kalkhoven, E., Kwakkenbos-Isbrücker, L., de Laat, S. W., van der Saag, P. T., and van der Burg, B. (1994). Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol. Cell. Endocrinol. 102, 45-52.
21. Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., and Wilson, E. M. (1995). Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 375, 581-585.
22. Kelce, W. R., and Wilson, E. M. (1997). Environmental anti-androgens: Developmental effects, molecular mechanisms and clinical implications. J. Mol. Med. 75, 198-207.
23. Kraus, W. L., Weis, K. E., and Katzenellenbogen, B. S. (1995). Inhibitory crosstalk between steroid hormone receptors: Differential targeting of estrogen receptor in the repression of transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15, 1847-1857.
24. Kuil, C. W., and Mulder, E. (1996). DNA-binding ability of androgen receptors in whole cells: Implications for the action of androgens and antiandrogens. Endocrinology 137, 1870-1877.
25. Legler, J., Broekhof, J. L. M., Brouwer, A., Lanser, P. H., Murk, A. J., van der Saag, P. T., Wester, P., Zivkovic, D., and van der Burg, B. (2000). A novel in vivo bioassay for (xeno-) estrogens using transgenic zebrafish. Environ. Sci. Technol. 34, 4439-4444.
26. Legler, J., van den Brink, C. E., Brouwer, A., Murk, A. J., van der Saag, P. T., Vethaak, A. D., and van der Burg, B. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci. 48, 55-66.
27. Lemmen, J. G., Arends, R. J., van Boxtel, A. L., van der Saag, P. T., and van der Burg, B. (2004). Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. J. Mol. Endocrinol. 32, 689-701.
28. Lemmen, J. G., van den Brink, C. E., Legler, J., van der Saag, P. T, and van der Burg, B. (2002). Detection of oestrogenic activity of steroids present during mammalian gestation using ERalpha and ERbeta specific in vitro assays. J. Endocrinol. 174, 435-446.
29. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995). The nuclear receptor superfamily: The second decade. Cell 83, 835-839.
30. Meyer, H. H. (2001). Biochemistry and physiology of anabolic hormones used for improvement of meat production. APMIS 109, 1-8.
31. McKenna, N. J., and O'Malley, B. W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474.
32. Nuclear Receptors Nomenclature Committee (1999). A Unified Nomenclature System for the Nuclear Receptor Superfamily. Cell 97, 161-163.
33. Ouatas, T., Clare, S. E., Hartsough, M. T., De La Rosa, A., and Steeg, P. S. (2002). MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Clin. Exp. Metastasis 19, 35-42.
34. Paris, F., Balaguer, P., Terouanne, B., Servant, N., Lacoste, C., Cravedi, J. P., Nicolas, J. C., and Sultan, C. (2002a). Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and antiandrogen activity in reporter cell lines. Mol. Cell. Endocrinol. 193, 43-49.
35. Paris, F., Servant, N., Terouanne, B., Balaguer, P. Nicolas, J. C., and Sultan, C. (2002b). A new recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J. Clin. Endocrinol. Metab. 87, 791-797.
36. Paris, F., Servant, N., Terouanne, B., and Sultan, C. (2002c). Evaluation of androgenic bioactivity in human serum by recombinant cell line: Preliminary results. Mol. Cell. Endocrinol. 198, 123-129.
37. Quaedackers, M. E., van den Brink, C. E., Wissink, S., Schreurs, R. H. M., Gustafsson, J. A., van der Saag, P. T., and van der Burg, B. (2001). 4-Hydroxytamoxifen Trans-represses nuclear factor-kB activity in human osteoblastic U2-OS cells through estrogen receptor (ER) alpha, and not through ERbeta. Endocrinology 142, 1156-1166.
38. Routledge, E. J., White, R., Parker, M. G., and Sumpter, J. P. (2000). Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ. J. Biol. Chem. 275, 35986-35993.
39. Schule, R., Muller, M., Kaltschmidt, C., and Renkawitz, R. (1988). Many transcription factors interact synergistically with steroid receptors. Science 242, 1418-1420.
40. Sohoni, P., and Sumpter, J. P. (1998). Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158, 327-339.
41. Sonneveld, E., Jansen, H. J., Riteco, J. A. C., Brouwer, A., and van der Burg, B. (2003). CALUX reporter cell lines as sensitive bioassays for monitoring biological activity of various classes of steroid hormones reveal the repressive effect of TCDD on the estrogen receptor. Organohal. Compounds 60, 263-266.
42. Sonneveld, E., van den Brink, C. E., van der Leede, B. M., Schulkes, R. K., Petkovich, M., van der Burg, B., and van der Saag, P. T. (1998). Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA, and can be induced through retinoic acid receptors in human breast and colon carcinoma cells. Cell Growth Differ. 9, 629-637.
43. Spangenberg, C., Eisfeld, K., Stunkel, W., Luger, K., Flaus, A., Richmond, T. J., Truss, M., and Beato, M. (1998). The mouse mammary tumour virus promoter positioned on a tetramer of histones H3 and H4 binds nuclear factor 1 and OTF1. J. Mol. Biol. 278, 725-739.
44. Sutherland, R. L., Hall, R. E., Pang, G. Y., Musgrove, E. A., and Clarke, C. L. (1988). Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. Cancer Res. 48, 4340-4347.
45. Terouanne, B., Tahiri, B., Georget, V., Belon, C., Poujol, N., Avances, C., Orio, F., Balaguer, P., and Sultan, C. (2000). A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol. Cell. Endocrinol. 160, 39-49.
46. Uchiumi, F., Sato, T., and Tanuma, S. (1998). Identification and characterization of a tannic acid-responsive negative regulatory element in the mouse mammary tumor virus promoter. J. Biol. Chem. 273, 12499-12508.
47. van den Bemd, G. J. C. M., Kuiper, G. G. J. M., Pols, H. A. P., and van Leeuwen, J. P. T. M. (1999). Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. Biochem. Biophys. Res. Commun. 261, 1-5.
48. van der Burg, B., Rutteman, G. R., Blankenstein, M. A., de Laat, S. W., and van Zoelen, E. J. (1988). Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J. Cell Physiol. 134, 101-108.
49. Vermeer, H., Hendriks-Stegeman, B. I., van den Brink, C. E., van der Saag, P. T., van der Burg, B., van Buul-Offers, S. C., and Jansen, M. (2003). A novel specific bioassay for the determination of glucocorticoid, bioavailability in human serum. Clin. Endocrinol. 59, 49-55.
50. Willemsen, P., Scippo, M., Kausel, G., Figueroa, J., Maghuin-Rogister, G., Martial, J. A., and Muller, M. (2004). Use of reporter cell lines for detection of endocrine-disrupter activity. Anal. Bioanal. Chem. 378, 655-663.
51. Wilson, V. S., Bobseine, K., Lambright, C. R., and Gray, L. E., Jr. (2002). A novel cell line, MDA-kb2 that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol. Sci. 66, 69-81.
52. Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., and Wilson, E. M. (1995). Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9, 208-218.